New study aims to catch transplanted pancreas cells failing before It's too late
NCT ID NCT07470593
First seen Mar 24, 2026 · Last updated Apr 25, 2026 · Updated 4 times
Summary
This study looks at 36 adults with type 1 diabetes who have received a pancreatic islet transplant. Researchers want to see if a continuous glucose monitor (CGM) can detect early loss of the transplanted cells' function. They will track a measure called "Time in Tight Range" (blood sugar between 70-140 mg/dL) over one year. The goal is to find a simple way to catch graft problems early, which could help improve long-term outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES (T1D) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hopitaux Universitaires de Strasbourg
RECRUITINGStrasbourg, 67200, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.